Using radiotherapy in low doses helps modulate the TME by increasing the infiltration of infused anti-tumor T cells and promoting beneficial changes, including the reduction of T-regs and TGF-β, and enhancing the proliferation of M1 macrophages, among others (13, 25). The gene discussed is TGFB1; the disease is neoplasm.